The global dementia drugs market is anticipated to grow at a significant CAGR around 8.1% during the forecast period. The global dementia drugs market is largely driven due to the increasing prevalence of target diseases, the introduction of new and innovative technologies and drugs, and increased government funding and awareness programs for dementia. Also, several market players are engaged in the implementation of strategic developments. For instance, in Feb 2020 a new initiative by McGill University’s Dementia Education Program is among the 15 projects that will receive funding from the public health agency of Canada to raise awareness of dementia and promote dementia-inclusive communities. For instance, in October 2021, the government in Kerala, India, launched the Dementia-Friendly District program, ‘Udbodh’.
Get Free Sample link @ https://www.omrglobal.com/request-sample/dementia-drugs-market
This initiative has been taken with a collaboration between Cochin University of Science and Technology’s NeuroScience department, in the Ernakulam district administration as well as Kochi Municipal Corporation. In Jan 2021 LSP the leading European life science investor launched the LSP Dementia Fund, a fund that is dedicated to combating neurodegenerative diseases. Such Initiatives will boost the awareness of dementia drugs, thereby contributing to market growth. However, factor such as high failure rates of drugs at the approval stage is expected to delay market growth over the forecast period.
Full report of Dementia Drugs Market available @ https://www.omrglobal.com/industry-reports/dementia-drugs-market
Market Coverage
- Segment Covered-
- By Dementia Type
- By Drugs Type
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Land- Teva Pharmaceuticals Industries Ltd., Merck & Co. Inc., Pfizer Inc., GlaxoSmithKline Plc, Aurobindo Pharma Ltd., Biogen Inc., and others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How does COVID-19 impact the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Dementia Drugs Market Report Segment
By Type of Dementia
- Lewy Body Dementia
- Parkinson’s Disease Dementia
- Alzheimer’s Diseases Dementia
- Others
By Type of Drugs
- Cholinesterase Inhibitors
- MAO Inhibitors
- GlutamateInhibitors
- Others
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/dementia-drugs-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
